Equibles does not estimate personal net worth.
Get an email with a short summary when Twist Bioscience Corp publishes a filing, an earnings call transcript or a press release.
Get TWST alertsJim Thorburn is recorded as CFO at Twist Bioscience Corp (TWST). Jim Thorburn has spoken on 8 earnings calls across 1 company, most recently for Twist Bioscience Corp on November 17, 2023. Twist Bioscience Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Twist Bioscience Corp includes Emily Leproust (CEO), Adam Laponis (CFO), Patrick Finn (COO) and 7 others.
“We’re happy to report we hit another record in orders and revenue for our fourth quarter and full fiscal year 2023. I want to thank all our Twisters, customers, and partners who made this possible.”
“We had a truly outstanding quarter with a record number of customers served despite a more difficult macroeconomic environment. Revenue for quarter three was $63.7 million, which is year-over-year growth of approximately 14% and a sequential increase of 6% and ahead of our guidance of $60 million to $61 million.”
“We had another great quarter and a terrific year of growth at Twist despite a volatile macroeconomic environment. Revenue for quarter four was $57.3 million, which brings our revenue for fiscal 2022 to $203.6 million with year-over-year growth of 54%.”
“We started off fiscal 2022 on a strong note as we continue to scale our platform. Revenue for quarter one was $42 million, which is a sequential growth of 11% and year-over-year growth of 49%.”
“As noted, our results continued to demonstrate the advances we're making in executing our business strategy and investing in our platform. Revenue for the third quarter is $35 million, a new record for Twist and up sequentially 12%, and year-over-year 65%.”
Biotechnology · Healthcare
CFO
